Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Heritage Cannabis Holdings Corp C.CANN

Alternate Symbol(s):  HERTF

Heritage Cannabis Holdings Corp. is a Canada-based cannabis company offering products to both the medical and recreational legal cannabis markets in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the United States. In Canada, it operates through its subsidiaries, Heritage Cannabis West Corporation (Heritage West) and Heritage Cannabis East Corporation (Heritage East). Heritage West holds a Health Canada issued cultivation, processing, and medical and adult use sales license, as well as an industrial hemp license, a cannabis oil sales license, and a cannabis research license. In the United States, it operates through, Opticann Inc., an oral and topical cannabinoid company.


CSE:CANN - Post by User

Comment by thelonghaul1979on Apr 05, 2018 5:56pm
91 Views
Post# 27839290

RE:RE:RE:RE:thelonghaul1979 - best post by far in the last month

RE:RE:RE:RE:thelonghaul1979 - best post by far in the last month My apologies, my math was a little off a few nights ago.  Apparently, they're using a little more room for vaults, offices, and trimming/processing that I thought.  However, the math still supports a significant SP once production is underway. I made a poor assumptiont about area utilization and I should have known better.  Here's the process I used.  I'm not proclaiming to be a finance guy, I'm an engineer so I'm using the information I've learned about finance to the best of my ability.  Please excuse the rudimentary calculations. 

Phase one square feet - 15,500
Phase two square feet - 41,400
Unused square footage - no real number here yet however, they're backing into 4,000 kg bud/grow so we'll use that.  This means that out of the 56,900 sq ft of usable space, they're growing in 40,000 sq ft of it.  
Grow quantity per cycle - 4,000 kg
Grows per year - 4 assuming 90-day grow cycles, could be more, some are making 6 grows a year on 60/day cycles (Source:  MJBizmagazine)
Grow quantity per year - 16,000 kg
Grow quantity per year in grams - 16,000,000 g
Per gram price - $4/gram
Annual revenue - $64,000,000 (CA)
Current P/S ratio trends in the industry - we'll use HIGHLY conservative numbers of 10X (FYI (Canopy P/S currently 60+, Aurora P/S currently 128+, Aphria P/S currently 150+) (Source: Investing.com/Financial/Ratios)
Float Volume -  162.583 MM shares
P/S Ratio Equation = (SP/(Sales/Float)) = 10 
Rearranging we get SP = 10(Sales/Float) = 10(64,000,000/162,583,866) = $3.93/share give or take assuming no dilution
Market Capitalization at this point = roughly $640,000,000 (CA)

By the way, if I'm making a catastrophe error is my assumptions or calculations, I want to know about it.  I'm not trying to spread bad information, trying to confuse, trying to pump, or attempting to mischaracterize anything.  This is very rough but it gets to my point of SP trending as progression occurs and resulting market caps as a function of annual revenue.  
Bullboard Posts